Prevalence of Past and Reactivated Viral Infections and Efficacy of Cyclosporine A as Monotherapy or in Combination in Patients with Psoriatic Arthritis—Synergy Study: A Longitudinal Observational Study

Table 4

Clinical assessment of psoriatic arthritis (PsA) and spondylitis in patients evaluable at baseline and at follow-up visits (median and IQR).

	Baseline	6 months	12 months
VAS, patients’ global assessment (no. = 144)	50 (30–71.5)	30 (12.5–50)*	20 (10–43)*
VAS, physicians’ global assessment (no. = 147)	40 (20–60)	20 (5–44)*	10 (5–30)*
BASDAI (no. = 61)	40.5 (24–60)	21 (7–38)*	20 (5–38)*

Patients’ and physicians’ global assessment was performed using the Visual Analogue Scale (VAS). *P < 0.0001 versus baseline.